Combined effects of PI3K and SRC kinase inhibitors with imatinib on intracellular calcium levels, autophagy, and apoptosis in CML-PBL cells-Reference-Cited by-同舟云学术

Combined effects of PI3K and SRC kinase inhibitors with imatinib on intracellular calcium levels, autophagy, and apoptosis in CML-PBL cells

Published:2013-09 Issue:17 Volume:12 Page:2839-2848
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Ciarcia Roberto,Damiano Sara,Montagnaro Serena,Pagnini Ugo,Ruocco Antonio,Caparrotti Giuseppe,d'Angelo Danila,Boffo Silvia,Morales Fátima,Rizzolio Flavio,Florio Salvatore,Giordano Antonio

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

http://www.tandfonline.com/doi/pdf/10.4161/cc.25920

Reference59 articles.

1. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia;O’Brien;N Engl J Med,2003

2. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia;Druker;N Engl J Med,2006

3. The CML stem cell: evolution of the progenitor;Stuart;Cell Cycle,2009

4. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification;Gorre;Science,2001

5. Imatinib therapy in chronic myelogenous leukemia: strategies to avoid and overcome resistance;Hochhaus;Leukemia,2004

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxidative Stress and Chronic Myeloid Leukemia: A Balance between ROS-Mediated Pro- and Anti-Apoptotic Effects of Tyrosine Kinase Inhibitors;Antioxidants;2024-04-13

2. Integrating computational methods guided the discovery of phytochemicals as potential Pin1 inhibitors for cancer: pharmacophore modeling, molecular docking, MM-GBSA calculations and molecular dynamics studies;Frontiers in Chemistry;2024-01-22

3. Ca2+ Signaling and Src Functions in Tumor Cells;Biomolecules;2023-12-03

4. The importance of personalized medicine in chronic myeloid leukemia management: a narrative review;Egyptian Journal of Medical Human Genetics;2023-04-06

5. Targeting Inflammation in Non-Small Cell Lung Cancer through Drug Repurposing;Pharmaceuticals;2023-03-16